Nolato Ab Class B · OMXSTO:NOLA_B
Nolato Ab Class B — Q2 2025 Earnings Presentation
12 slides from Nolato Ab Class B's earnings presentation, Jul 18, 2025
Slide 1: Second quarter
Medical Solutions Engineered Solutions Second quarter CEO Christer Wahlquist CFO Per-Ola Holmström 18 July, 2025
Slide 2: Q2 summary – Nolato Group
Q2 summary – Nolato Group A global solutions provider established on three continents ● Sales amounted to SEK 2,395 million (2,439) - Organic growth of 4%, adjusted for currency SEKm 12000 - Growth in both business areas 11000 ● Operating profit (EBITA) rose by 13% to SEK 277 10000 million (245) 900
Slide 3: One Group – two business areas
One Group – two business areas Nolato Medical Solutions Engineered Solutions Our offering as a strategic partner for selected Development and manufacture of complex Design, development, industrialization and global customers comprises development and product systems and components for medical manufa
Slide 4: Medical Solutions – sustainable growth and global expansion
Medical Solutions – sustainable growth and global expansion SEKm 5500 5000 4500 4000 3500 3000 1,354 170 2500 SALES EBITA 2000 SEKm, Q2 SEKm, Q2 1500 56 12.6 1000 500 SHARE OF THE GROUP EBITA MARGIN %, Q2 %, Q2 0 05 06 07 08 09 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 R12M 4 4
Slide 5: Medical Solutions – focused product areas
Medical Solutions – focused product areas Pharma Diagnostics Medical Devices Drug Delivery In-vitro-diagnostics (IVD) Endoscopy & General Surgery Cardiology Continence care Pharma Packaging Other 5
Slide 6: Medical Solutions – Q2
Medical Solutions – Q2 ● Sales totaled SEK 1,354 million (1,365) - An increase of 5% adjusted for currency Q2 Acc. 6 months - The Drug Delivery market area continued to grow; increase for most products - Other showed good growth, for example new eye care products SEKm 2025 2024 2025 2024 - IVD showe
Slide 7: Engineered Solutions – advanced technology and high-productivity manufacturing
Engineered Solutions – advanced technology and high-productivity manufacturing SEKm 8000 7500 7000 6500 6000 5500 5000 4500 4000 1,044 117 3500 3000 SALES EBITA 2500 SEKm, Q2 SEKm, Q2 2000 1500 44 11.2 1000 500 SHARE OF THE GROUP EBITA MARGIN 0 %, Q2 %, Q2 05 06 07 08 09 10 11 12 13 14 15 16 17 18 1
Slide 8: Engineered Solutions – focused product areas
Engineered Solutions – focused product areas Materials Consumer Electronics Automotive Other Hygiene 8
Slide 9: Engineered Solutions – Q2
Engineered Solutions – Q2 ● Sales totaled SEK 1,044 million (1,077) Q2 Acc. 6 months - Increase of 1% adjusted for currency SEKm 2025 2024 2025 2024 - Continued positive performance for the Hygiene market area Sales 1,044 1,077 2,102 2,164 - Consumer electronics increased, mainly through investments
Slide 10: Group financial highlights
Group financial highlights Full Q2 Q2 Acc. 6 months year SEKm 2025 2024 2025 2024 R12M 2024 Net sales 2,395 2,439 4,848 4,881 9,631 9,664 Operating profit (EBITA) 277 245 548 483 1,023 958 EBITA margin (%) 11.6 10.0 11.3 9.9 10.6 9.9 Profit after financial income and expense 264 215 516 424 940 848
Slide 11: Current situation
Current situation Medical Solutions Engineered Solutions • Maintained growth strategy – high market activity • Advanced market positions • Focus on margin – implemented cost adjustments and • Established position in new product areas increased efficiency • Focus on innovative and sustainable solutio
Slide 12: Thank you.
Thank you. This presentation may contain forward-looking statements. When used in this presentation, words such as “anticipate”, “believe”, “estimate”, “expect”, “plan” and “project” are intended to identify forward-looking statements. Such statements could encompass risks and uncertainties pertaini